By Ed Prideaux — 2021
The growing legitimacy of psychedelics as therapies promises to transform how we view the extraordinary, writes Ed Prideaux.
Read on www.bbc.com
CLEAR ALL
Regulators will soon grapple with how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.
1
The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.
The world’s leading advocate for the medicinal use of psychedelics on the ghost of Timothy Leary, why Ecstasy could cure PTSD, and the best place to trip in Boston.
Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look.
A new study hints at a novel and promising treatment for alcohol use disorder.
The psychedelic drug LSD can help people with alcoholism quit or cut back their drinking, according to a new analysis of data originally collected in the 1960s. The study adds to a renaissance of research interest in mind-expanding medications for psychiatric disorders.
My first psilocybin journey began around an altar in the middle of a second-story loft in a suburb of a small city on the Eastern Seaboard.
2
Roland Griffiths' psilocybin experiments have produced striking evidence for therapeutic uses of hallucinogens.
A new generation of research into psilocybin could change how we treat numerous mental health conditions.
Scientists Roland Griffiths and Matthew Johnson sit down with journalist Anderson Cooper to discuss the promise of psychedelics as a form of treatment for anxiety, depression, addiction, and more.